STORY HIGHLIGHTS


Expert: China's COVID-19 vaccine trial results "very impressive"

CNC
Added On May 28, 2020

A study published recently by medical journal The Lancet shows that China's vaccine trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-COV-2 in humans. Robert Schooley, a professor of medicine at the University of California,said that vaccine recipients generated potent immune responses against the coronavirus. Schooley said the immunogenicity results from the study are very impressive as everyone had a T-cell response and most had an over four-fold increase in neutralizing antibodies by day 28. He said the next steps will be to see whether there are differences in immunogenicity in older people and how long the immunity persists. According to The Lancet, the trial demonstrates promising results after 28 days, and the final results will be evaluated in six months.